In contrast, additional Alectinib treatment induced phosphatidylserine exposure in all three human cancer cell lines, around 26% of the NCI-H460, 18% of NCI-H1299 and 26% of the MDA-MB-231 cells were positive for Annexin V-FITC staining (Fig. 4). The gene discussed is ANXA5; the disease is cancer.